Digenic inheritance of severe insulin resistance in a human pedigree (original) (raw)

Nature Genetics volume 31, pages 379–384 (2002)Cite this article

An Erratum to this article was published on 01 September 2002

This article has been updated

Abstract

Impaired insulin action is a key feature of type 2 diabetes and is also found, to a more extreme degree, in familial syndromes of insulin resistance. Although inherited susceptibility to insulin resistance may involve the interplay of several genetic loci, no clear examples of interactions among genes have yet been reported. Here we describe a family in which five individuals with severe insulin resistance, but no unaffected family members, were doubly heterozygous with respect to frameshift/premature stop mutations in two unlinked genes, PPARG and PPP1R3A these encode peroxisome proliferator activated receptor γ, which is highly expressed in adipocytes, and protein phosphatase 1, regulatory subunit 3, the muscle-specific regulatory subunit of protein phosphatase 1, which are centrally involved in the regulation of carbohydrate and lipid metabolism, respectively. That mutant molecules primarily involved in either carbohydrate or lipid metabolism can combine to produce a phenotype of extreme insulin resistance provides a model of interactions among genes that may underlie common human metabolic disorders such as type 2 diabetes.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 12 print issues and online access

$209.00 per year

only $17.42 per issue

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Similar content being viewed by others

Change history

The word 'compound' was changed to 'doubly'; the full text was updated, the pdf was appended with a note. An erratum will be published in the September issue.

Notes

  1. NOTE: Owing to a copy-editing error that was implemented after the authors returned the corrected proofs, the term 'doubly heterozygous' was substituted with the term 'compound heterozygous' throughout the text and in Table 1. Similarly, 'double heterozygotes' was erroneously substituted with 'compound heterozygotes'. The full text of the online version of the Letter, including Table 1, has been corrected. Per company policy, the PDF version has not been corrected; an erratum will be published in an upcoming issue. Nature Genetics sincerely regrets these errors.

References

  1. Barroso, I. et al. Dominant negative mutations in human PPARγ associated with severe insulin resistance, diabetes mellitus and hypertension. Nature 402, 880–883 (1999).
    Article CAS Google Scholar
  2. Rosen, E.D. & Spiegelman, B.M. Pparγ: a nuclear regulator of metabolism, differentiation, and cell growth. J. Biol. Chem. 276, 37731–37734 (2001).
    Article CAS Google Scholar
  3. Mukherjee, R. et al. Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists. Nature 386, 407–410 (1997).
    Article CAS Google Scholar
  4. Olefsky, J.M. Treatment of insulin resistance with peroxisome proliferator-activated receptor γ agonists. J. Clin. Invest. 106, 467–472 (2000).
    Article CAS Google Scholar
  5. Yamauchi, T. et al. Inhibition of RXR and PPARγ ameliorates diet-induced obesity and type 2 diabetes. J. Clin. Invest. 108, 1001–1013 (2001).
    Article CAS Google Scholar
  6. Kubota, N. et al. PPARγ mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Mol. Cell. 4, 597–609 (1999).
    Article CAS Google Scholar
  7. Miles, P.D., Barak, Y., He, W., Evans, R.M. & Olefsky, J.M. Improved insulin-sensitivity in mice heterozygous for PPAR-γ deficiency. J. Clin. Invest. 105, 287–292 (2000).
    Article CAS Google Scholar
  8. Bjorntorp, P. and Sjostrom, L. Carbohydrate storage in man: speculations and some quantitative considerations. Metabolism 27, 1853–1865 (1978).
    Article CAS Google Scholar
  9. Newgard, C.B., Brady, M.J., O'Doherty, R.M. & Saltiel, A.R. Organizing glucose disposal: emerging roles of the glycogen targeting subunits of protein phosphatase-1. Diabetes 49, 1967–1977 (2000).
    Article CAS Google Scholar
  10. Suzuki, Y., et al. Insulin control of glycogen metabolism in knockout mice lacking the muscle-specific phosphatase PP1G/RGL. Mol. Cell. Biol. 21, 2683–2694 (2001).
    Article CAS Google Scholar
  11. Nielsen, J.N. et al. Glycogen synthase localization and activity in rat skeletal muscle is strongly dependent on glycogen content. J. Physiol. 531, 757–769 (2001).
    Article CAS Google Scholar
  12. Burghes, A.H., Vaessin, H.E. & de La Chapelle, A. Genetics. The land between Mendelian and multifactorial inheritance. Science 293, 2213–2214 (2001).
    Article CAS Google Scholar
  13. Bruning, J.C. et al. Development of a novel polygenic model of NIDDM in mice heterozygous for IR and IRS-1 null alleles. Cell 88, 561–572 (1997).
    Article CAS Google Scholar
  14. Birnbaum, M.J. Diabetes. Dialogue between muscle and fat. Nature 409, 672–673 (2001).
    Article CAS Google Scholar
  15. Abel, E.D. et al. Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature 409, 729–733 (2001).
    Article CAS Google Scholar
  16. Steppan, C.M. & Lazar, M.A. Resistin and obesity-associated insulin resistance. Trends Endocrinol. Metab. 13, 18–23 (2002).
    Article CAS Google Scholar
  17. Kelley, D.E. & Goodpaster, B.H. Skeletal muscle triglyceride. An aspect of regional adiposity and insulin resistance. Diabetes Care 24, 933–941 (2001).
    Article CAS Google Scholar
  18. McGarry, J.D. What if Minkowski had been ageusic? An alternative angle on diabetes. Science 258, 766–770 (1992).
    Article CAS Google Scholar
  19. Zhang, L. et al. Whole genome amplification from a single cell: implications for genetic analysis. Proc. Natl Acad. Sci. USA 89, 5847–5851 (1992).
    Article CAS Google Scholar
  20. Thorpe, K.L., Schafer, A.J., Genin, E., Trowsdale, J. & Beck, S. Detection of polymorphism in the RING3 gene by high-throughput fluorescent SSCP analysis. Immunogenetics 49, 256–265 (1999).
    Article CAS Google Scholar
  21. Collingwood, T.N., Adams, M., Tone, Y. & Chatterjee, V.K. Spectrum of transcriptional, dimerization, and dominant negative properties of twenty different mutant thyroid hormone β-receptors in thyroid hormone resistance syndrome. Mol. Endocrinol. 8, 1262–1277 (1994).
    CAS PubMed Google Scholar
  22. Zamir, I., Zhang, J. & Lazar, M.A. Stoichiometric and steric principles governing repression by nuclear hormone receptors. Genes Dev. 11, 835–846 (1997).
    Article CAS Google Scholar
  23. Forman, B.M. et al. 15-Deoxy-Δ12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ. Cell 83, 803–812 (1995).
    Article CAS Google Scholar
  24. Rasmussen, S.K. et al. Adenovirus-mediated expression of a naturally occurring Asp905Tyr variant of the glycogen-associated regulatory subunit of protein phosphatase-1 in L6 myotubes. Diabetologia 43, 718–722 (2000).
    Article CAS Google Scholar
  25. Rico-Sanz, J. et al. Diversity in levels of intracellular total creatine and triglycerides in human skeletal muscles observed by (1)H-MRS. J. Appl. Physiol. 87, 2068–2072 (1999).
    Article CAS Google Scholar
  26. Tang, P.M., Bondor, J.A., Swiderek, K.M. & DePaoli-Roach, A.A. Molecular cloning and expression of the regulatory (RGI) subunit of the glycogen-associated protein phosphatase. J. Biol. Chem. 266, 15782–15789 (1991).
    CAS PubMed Google Scholar
  27. Thomas, E.L. et al. Magnetic resonance imaging of total body fat. J. Appl. Physiol. 85, 1778–1785 (1998).
    Article CAS Google Scholar
  28. Black, D. et al. Obesity. A report of the Royal College of Physicians. J. R. Coll. Physicians Lond. 17, 5–65 (1983).
    Google Scholar
  29. Matthews, D.R. et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412–419 (1985).
    Article CAS Google Scholar

Download references

Acknowledgements

This study drew upon the combined efforts of many individuals at Incyte Genomics Cambridge, to whom we extend our appreciation. We thank the patients and their families who participated in this study, P. Luzio for helpful discussion, V. Ibbotson for assistance with clinical investigations, K. Ong for HOMA analysis and I. Halsall for insulin and leptin measurements. D.B.S. is a Wellcome Trust Training Fellow, and S.O'R. and V.K.K.C. are supported by the Wellcome Trust. A.M. is funded by an Individual Marie Curie Fellowship. N.J.W., A.H.H., E.L.T. and J.D.B. are supported by the Medical Research Council.

Author information

Author notes

  1. David B. Savage, Maura Agostini, Inês Barroso, Mark Gurnell and Jian'an Luan: These authors contributed equally to this work.

Authors and Affiliations

  1. Department of Clinical Biochemistry, University of Cambridge, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 2QQ, UK
    David B. Savage, Aline Meirhaeghe, Gudrun Ihrke, Maria A. Soos, Stella George, Dirk Berger, Antonio Vidal-Puig & Stephen O'Rahilly
  2. Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 2QQ, UK
    David B. Savage, Maura Agostini, Mark Gurnell, Aline Meirhaeghe, Odelia Rajanayagam, Maria A. Soos, Stella George, Dirk Berger, Antonio Vidal-Puig, Stephen O'Rahilly & V. Krishna K. Chatterjee
  3. Incyte Genomics, Palo Alto, 3160 Porter Drive, California, USA
    Inês Barroso & Alan J. Schafer
  4. Department of Public Health, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK
    Jian'an Luan, Anne-Helen Harding & Nicholas J. Wareham
  5. The Robert Steiner MRI Unit, MRC Clinical Sciences Centre, Imperial College School of Medicine, Hammersmith Hospital, London, UK
    E. Louise Thomas & Jimmy D. Bell
  6. Department of Endocrinology, Imperial College Faculty of Medicine, Charing Cross and Hammersmith Hospitals, London, UK
    Karim Meeran
  7. Division of Clinical Sciences, University of Sheffield, Sheffield, UK
    Richard J. Ross

Authors

  1. David B. Savage
    You can also search for this author inPubMed Google Scholar
  2. Maura Agostini
    You can also search for this author inPubMed Google Scholar
  3. Inês Barroso
    You can also search for this author inPubMed Google Scholar
  4. Mark Gurnell
    You can also search for this author inPubMed Google Scholar
  5. Jian'an Luan
    You can also search for this author inPubMed Google Scholar
  6. Aline Meirhaeghe
    You can also search for this author inPubMed Google Scholar
  7. Anne-Helen Harding
    You can also search for this author inPubMed Google Scholar
  8. Gudrun Ihrke
    You can also search for this author inPubMed Google Scholar
  9. Odelia Rajanayagam
    You can also search for this author inPubMed Google Scholar
  10. Maria A. Soos
    You can also search for this author inPubMed Google Scholar
  11. Stella George
    You can also search for this author inPubMed Google Scholar
  12. Dirk Berger
    You can also search for this author inPubMed Google Scholar
  13. E. Louise Thomas
    You can also search for this author inPubMed Google Scholar
  14. Jimmy D. Bell
    You can also search for this author inPubMed Google Scholar
  15. Karim Meeran
    You can also search for this author inPubMed Google Scholar
  16. Richard J. Ross
    You can also search for this author inPubMed Google Scholar
  17. Antonio Vidal-Puig
    You can also search for this author inPubMed Google Scholar
  18. Nicholas J. Wareham
    You can also search for this author inPubMed Google Scholar
  19. Stephen O'Rahilly
    You can also search for this author inPubMed Google Scholar
  20. V. Krishna K. Chatterjee
    You can also search for this author inPubMed Google Scholar
  21. Alan J. Schafer
    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence toStephen O'Rahilly.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Rights and permissions

About this article

Cite this article

Savage, D., Agostini, M., Barroso, I. et al. Digenic inheritance of severe insulin resistance in a human pedigree.Nat Genet 31, 379–384 (2002). https://doi.org/10.1038/ng926

Download citation